Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Acute nonrheumatic streptococcal myocarditis resembling ST-elevation acute myocardial infarction in a young patient.

Proceedings (Baylor University. Medical Center)

Aguirre JL, Jurado M, Porres-Aguilar M, Olivas-Chacon C, Porres-Muñoz M, Mukherjee D, Taveras J.
PMID: 25829649
Proc (Bayl Univ Med Cent). 2015 Apr;28(2):188-90. doi: 10.1080/08998280.2015.11929224.

Acute myocarditis can be induced by various concomitant disease processes including infections. Most of these cases are viral in origin; however, bacterial infections are also implicated to a lesser degree. Group A streptococcus is a frequent culprit in bacterial-induced...

Cite
Aguirre JL, Jurado M, Porres-Aguilar M, et al. Acute nonrheumatic streptococcal myocarditis resembling ST-elevation acute myocardial infarction in a young patient. Proc (Bayl Univ Med Cent). 2015;28(2):188-90doi: 10.1080/08998280.2015.11929224.
Aguirre, J. L., Jurado, M., Porres-Aguilar, M., Olivas-Chacon, C., Porres-Muñoz, M., Mukherjee, D., & Taveras, J. (2015). Acute nonrheumatic streptococcal myocarditis resembling ST-elevation acute myocardial infarction in a young patient. Proceedings (Baylor University. Medical Center), 28(2), 188-90. https://doi.org/10.1080/08998280.2015.11929224
Aguirre, Jose L, et al. "Acute nonrheumatic streptococcal myocarditis resembling ST-elevation acute myocardial infarction in a young patient." Proceedings (Baylor University. Medical Center) vol. 28,2 (2015): 188-90. doi: https://doi.org/10.1080/08998280.2015.11929224
Aguirre JL, Jurado M, Porres-Aguilar M, Olivas-Chacon C, Porres-Muñoz M, Mukherjee D, Taveras J. Acute nonrheumatic streptococcal myocarditis resembling ST-elevation acute myocardial infarction in a young patient. Proc (Bayl Univ Med Cent). 2015 Apr;28(2):188-90. doi: 10.1080/08998280.2015.11929224. PMID: 25829649; PMCID: PMC4365115.
Copy Download .nbib Format: NLM
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions.

Research and practice in thrombosis and haemostasis

Porres-Aguilar M, Jiménez D, Porres-Muñoz M, Mukherjee D.
PMID: 31624797
Res Pract Thromb Haemost. 2019 Aug 09;3(4):769. doi: 10.1002/rth2.12249. eCollection 2019 Oct.

No abstract available.

Cite
Porres-Aguilar M, Jiménez D, Porres-Muñoz M, et al. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost. 2019;3(4):769doi: 10.1002/rth2.12249.
Porres-Aguilar, M., Jiménez, D., Porres-Muñoz, M., & Mukherjee, D. (2019). Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Research and practice in thrombosis and haemostasis, 3(4), 769. https://doi.org/10.1002/rth2.12249
Porres-Aguilar, Mateo, et al. "Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions." Research and practice in thrombosis and haemostasis vol. 3,4 (2019): 769. doi: https://doi.org/10.1002/rth2.12249
Porres-Aguilar M, Jiménez D, Porres-Muñoz M, Mukherjee D. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost. 2019 Aug 09;3(4):769. doi: 10.1002/rth2.12249. eCollection 2019 Oct. PMID: 31624797; PMCID: PMC6781912.
Copy Download .nbib Format: NLM
The dilemma of refractory hypoxemia after inferior wall myocardial infarction.

Proceedings (Baylor University. Medical Center)

Albaghdadi A, Teleb M, Porres-Aguilar M, Porres-Munoz M, Marmol-Velez A.
PMID: 29686558
Proc (Bayl Univ Med Cent). 2018 Feb 01;31(1):67-69. doi: 10.1080/08998280.2017.1401347. eCollection 2018 Jan.

Patent foramen ovale (PFO) occurs in 25% of people. The decision on whether to close the PFO found after myocardial infarction and specifically right ventricular infarction is debated, with no solid guidelines addressing this subject. Here we present the...

Cite
Albaghdadi A, Teleb M, Porres-Aguilar M, et al. The dilemma of refractory hypoxemia after inferior wall myocardial infarction. Proc (Bayl Univ Med Cent). 2018;31(1):67-69doi: 10.1080/08998280.2017.1401347.
Albaghdadi, A., Teleb, M., Porres-Aguilar, M., Porres-Munoz, M., & Marmol-Velez, A. (2018). The dilemma of refractory hypoxemia after inferior wall myocardial infarction. Proceedings (Baylor University. Medical Center), 31(1), 67-69. https://doi.org/10.1080/08998280.2017.1401347
Albaghdadi, Aymen, et al. "The dilemma of refractory hypoxemia after inferior wall myocardial infarction." Proceedings (Baylor University. Medical Center) vol. 31,1 (2018): 67-69. doi: https://doi.org/10.1080/08998280.2017.1401347
Albaghdadi A, Teleb M, Porres-Aguilar M, Porres-Munoz M, Marmol-Velez A. The dilemma of refractory hypoxemia after inferior wall myocardial infarction. Proc (Bayl Univ Med Cent). 2018 Feb 01;31(1):67-69. doi: 10.1080/08998280.2017.1401347. eCollection 2018 Jan. PMID: 29686558; PMCID: PMC5903505.
Copy Download .nbib Format: NLM
[Complicaciones trombóticas en COVID-19 grave: enfoque en tromboembolia venosa, tromboprofilaxis y anticoagulación].

Cirugia y cirujanos

Porres-Aguilar M, Guerrero-de León MC, Grimaldo-Gómez FA, Izaguirre-Ávila R, Cabrera-Rayo A, Santos-Martínez LE, Sánchez-Medina JR, Porres-Muñoz M, Carrillo-Esper R.
PMID: 33296354
Cir Cir. 2020 Dec 09; doi: 10.24875/CIRU.20000879. Epub 2020 Dec 09.

La enfermedad grave por coronavirus 2019 (COVID-19) está causada por el Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) y predispone a complicaciones trombóticas. En esta revisión se aborda de manera práctica la estrecha relación entre la tromboembolia venosa y la...

Cite
Porres-Aguilar M, Guerrero-de León MC, Grimaldo-Gómez FA, et al. [Complicaciones trombóticas en COVID-19 grave: enfoque en tromboembolia venosa, tromboprofilaxis y anticoagulación]. Cir Cir. 2020;doi: 10.24875/CIRU.20000879.
Porres-Aguilar, M., Guerrero-de León, M. C., Grimaldo-Gómez, F. A., Izaguirre-Ávila, R., Cabrera-Rayo, A., Santos-Martínez, L. E., Sánchez-Medina, J. R., Porres-Muñoz, M., & Carrillo-Esper, R. (2020). [Complicaciones trombóticas en COVID-19 grave: enfoque en tromboembolia venosa, tromboprofilaxis y anticoagulación]. Cirugia y cirujanos, . https://doi.org/10.24875/CIRU.20000879
Porres-Aguilar, Mateo, et al. "[Complicaciones trombóticas en COVID-19 grave: enfoque en tromboembolia venosa, tromboprofilaxis y anticoagulación]." Cirugia y cirujanos vol. (2020). doi: https://doi.org/10.24875/CIRU.20000879
Porres-Aguilar M, Guerrero-de León MC, Grimaldo-Gómez FA, Izaguirre-Ávila R, Cabrera-Rayo A, Santos-Martínez LE, Sánchez-Medina JR, Porres-Muñoz M, Carrillo-Esper R. [Complicaciones trombóticas en COVID-19 grave: enfoque en tromboembolia venosa, tromboprofilaxis y anticoagulación]. Cir Cir. 2020 Dec 09; doi: 10.24875/CIRU.20000879. Epub 2020 Dec 09. Esperanto. PMID: 33296354.
Copy Download .nbib Format: NLM
Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma.

Case reports in pulmonology

Sabet Y, Ramirez S, Rosell Cespedes E, Rensoli Velasquez M, Porres-Muñoz M, Gaur S, Figueroa-Casas JB, Porres-Aguilar M.
PMID: 27190667
Case Rep Pulmonol. 2016;2016:2359437. doi: 10.1155/2016/2359437. Epub 2016 Apr 17.

Acute pulmonary toxicity associated with brentuximab appears to be a rare but serious adverse effect that can be potentially fatal. We report the case of a twenty-nine-year-old female with Hodgkin's lymphoma who was treated with brentuximab and later presented...

Cite
Sabet Y, Ramirez S, Rosell Cespedes E, et al. Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma. Case Rep Pulmonol. 2016;2016:2359437doi: 10.1155/2016/2359437.
Sabet, Y., Ramirez, S., Rosell Cespedes, E., Rensoli Velasquez, M., Porres-Muñoz, M., Gaur, S., Figueroa-Casas, J. B., & Porres-Aguilar, M. (2016). Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma. Case reports in pulmonology, 20162359437. https://doi.org/10.1155/2016/2359437
Sabet, Yasmin, et al. "Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma." Case reports in pulmonology vol. 2016 (2016): 2359437. doi: https://doi.org/10.1155/2016/2359437
Sabet Y, Ramirez S, Rosell Cespedes E, Rensoli Velasquez M, Porres-Muñoz M, Gaur S, Figueroa-Casas JB, Porres-Aguilar M. Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma. Case Rep Pulmonol. 2016;2016:2359437. doi: 10.1155/2016/2359437. Epub 2016 Apr 17. PMID: 27190667; PMCID: PMC4852124.
Copy Download .nbib Format: NLM
Frequency of .

Experimental and therapeutic medicine

Contreras-Capetillo SN, Blanco HL, Cerda-Flores RM, Lugo-Trampe J, Torres-Muñoz I, Bravo-Oro A, Esmer C, DE Villarreal LE.
PMID: 26136935
Exp Ther Med. 2015 Jun;9(6):2053-2058. doi: 10.3892/etm.2015.2436. Epub 2015 Apr 20.

Individuals who suffer from spinal muscular atrophy (SMA) exhibit progressive muscle weakness that frequently results in mortality in the most severe forms of the disease. In 98% of cases, there is a homozygous deletion of the survival of motor...

Cite
Contreras-Capetillo SN, Blanco HL, Cerda-Flores RM, et al. Frequency of . Exp Ther Med. 2015;9(6):2053-2058doi: 10.3892/etm.2015.2436.
Contreras-Capetillo, S. N., Blanco, H. L., Cerda-Flores, R. M., Lugo-Trampe, J., Torres-Muñoz, I., Bravo-Oro, A., Esmer, C., & DE Villarreal, L. E. (2015). Frequency of . Experimental and therapeutic medicine, 9(6), 2053-2058. https://doi.org/10.3892/etm.2015.2436
Contreras-Capetillo, Silvina Noemi, et al. "Frequency of ." Experimental and therapeutic medicine vol. 9,6 (2015): 2053-2058. doi: https://doi.org/10.3892/etm.2015.2436
Contreras-Capetillo SN, Blanco HL, Cerda-Flores RM, Lugo-Trampe J, Torres-Muñoz I, Bravo-Oro A, Esmer C, DE Villarreal LE. Frequency of . Exp Ther Med. 2015 Jun;9(6):2053-2058. doi: 10.3892/etm.2015.2436. Epub 2015 Apr 20. PMID: 26136935; PMCID: PMC4473530.
Copy Download .nbib Format: NLM
Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension.

Proceedings (Baylor University. Medical Center)

Porres-Aguilar M, Al-Bayati I, Porres-Muñoz M, Padilla O, Syed SH, Lowder K, Azimova K, Fan J, Mukherjee D, Abbas A.
PMID: 26130886
Proc (Bayl Univ Med Cent). 2015 Jul;28(3):350-2. doi: 10.1080/08998280.2015.11929271.

Pulmonary veno-occlusive disease (PVOD) represents a rare form of precapillary pulmonary arterial hypertension. We present a young patient hospitalized with progressive dyspnea, with initial workup suggestive of pulmonary hypertension and unexplained noncardiogenic pulmonary edema. His subsequent clinical course was...

Cite
Porres-Aguilar M, Al-Bayati I, Porres-Muñoz M, et al. Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension. Proc (Bayl Univ Med Cent). 2015;28(3):350-2doi: 10.1080/08998280.2015.11929271.
Porres-Aguilar, M., Al-Bayati, I., Porres-Muñoz, M., Padilla, O., Syed, S. H., Lowder, K., Azimova, K., Fan, J., Mukherjee, D., & Abbas, A. (2015). Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension. Proceedings (Baylor University. Medical Center), 28(3), 350-2. https://doi.org/10.1080/08998280.2015.11929271
Porres-Aguilar, Mateo, et al. "Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension." Proceedings (Baylor University. Medical Center) vol. 28,3 (2015): 350-2. doi: https://doi.org/10.1080/08998280.2015.11929271
Porres-Aguilar M, Al-Bayati I, Porres-Muñoz M, Padilla O, Syed SH, Lowder K, Azimova K, Fan J, Mukherjee D, Abbas A. Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension. Proc (Bayl Univ Med Cent). 2015 Jul;28(3):350-2. doi: 10.1080/08998280.2015.11929271. PMID: 26130886; PMCID: PMC4462219.
Copy Download .nbib Format: NLM
Cardiac metastasis from liposarcoma to the right ventricle complicated by massive pulmonary tumor embolism.

Archivos de cardiologia de Mexico

Porres-Aguilar M, DeCicco I, Anaya-Ayala JE, Porres-Muñoz M, Santos-Martínez LE, Flores-García CA, Osorio H.
PMID: 31588131
Arch Cardiol Mex. 2019;89(3):279-282. doi: 10.24875/ACM.M19000036.

No abstract available.

Cite
Porres-Aguilar M, DeCicco I, Anaya-Ayala JE, et al. Metástasis cardíacas por liposarcoma a ventrículo derecho complicado con embolismo tumoral pulmonar masivo. Cardiac metastasis from liposarcoma to the right ventricle complicated by massive pulmonary tumor embolism. Arch Cardiol Mex. 2019;89(3):279-282doi: 10.24875/ACM.M19000036.
Porres-Aguilar, M., DeCicco, I., Anaya-Ayala, J. E., Porres-Muñoz, M., Santos-Martínez, L. E., Flores-García, C. A., & Osorio, H. (2019). Metástasis cardíacas por liposarcoma a ventrículo derecho complicado con embolismo tumoral pulmonar masivo. Cardiac metastasis from liposarcoma to the right ventricle complicated by massive pulmonary tumor embolism. Archivos de cardiologia de Mexico, 89(3), 279-282. https://doi.org/10.24875/ACM.M19000036
Porres-Aguilar, Mateo, et al. "Metástasis cardíacas por liposarcoma a ventrículo derecho complicado con embolismo tumoral pulmonar masivo." Cardiac metastasis from liposarcoma to the right ventricle complicated by massive pulmonary tumor embolism. Archivos de cardiologia de Mexico vol. 89,3 (2019): 279-282. doi: https://doi.org/10.24875/ACM.M19000036
Porres-Aguilar M, DeCicco I, Anaya-Ayala JE, Porres-Muñoz M, Santos-Martínez LE, Flores-García CA, Osorio H. Metástasis cardíacas por liposarcoma a ventrículo derecho complicado con embolismo tumoral pulmonar masivo. Cardiac metastasis from liposarcoma to the right ventricle complicated by massive pulmonary tumor embolism. Arch Cardiol Mex. 2019;89(3):279-282. doi: 10.24875/ACM.M19000036. PMID: 31588131.
Copy Download .nbib Format: NLM
Candidate gene polymorphisms and risk of psoriasis: A pilot study.

Experimental and therapeutic medicine

Villarreal-Martínez A, Gallardo-Blanco H, Cerda-Flores R, Torres-Muñoz I, Gómez-Flores M, Salas-Alanís J, Ocampo-Candiani J, Martínez-Garza L.
PMID: 27073425
Exp Ther Med. 2016 Apr;11(4):1217-1222. doi: 10.3892/etm.2016.3066. Epub 2016 Feb 09.

Psoriasis is a complex genetic disease, which has previously been associated with numerous single nucleotide polymorphisms (SNPs) that are implicated in various processes, including skin barrier functions and in the regulation of inflammatory and immune responses. The present study...

Cite
Villarreal-Martínez A, Gallardo-Blanco H, Cerda-Flores R, et al. Candidate gene polymorphisms and risk of psoriasis: A pilot study. Exp Ther Med. 2016;11(4):1217-1222doi: 10.3892/etm.2016.3066.
Villarreal-Martínez, A., Gallardo-Blanco, H., Cerda-Flores, R., Torres-Muñoz, I., Gómez-Flores, M., Salas-Alanís, J., Ocampo-Candiani, J., & Martínez-Garza, L. (2016). Candidate gene polymorphisms and risk of psoriasis: A pilot study. Experimental and therapeutic medicine, 11(4), 1217-1222. https://doi.org/10.3892/etm.2016.3066
Villarreal-Martínez, Alejandra, et al. "Candidate gene polymorphisms and risk of psoriasis: A pilot study." Experimental and therapeutic medicine vol. 11,4 (2016): 1217-1222. doi: https://doi.org/10.3892/etm.2016.3066
Villarreal-Martínez A, Gallardo-Blanco H, Cerda-Flores R, Torres-Muñoz I, Gómez-Flores M, Salas-Alanís J, Ocampo-Candiani J, Martínez-Garza L. Candidate gene polymorphisms and risk of psoriasis: A pilot study. Exp Ther Med. 2016 Apr;11(4):1217-1222. doi: 10.3892/etm.2016.3066. Epub 2016 Feb 09. PMID: 27073425; PMCID: PMC4812537.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries